NOTE: This is satire
What a year it was for the marijuana sector, bouncing back from a challenging 2014. While the sector ended the year well below the 2014 highs despite more than tripling in price, investors are optimistic that the election cycle in 2016 could allow the market to test those levels, especially as it looks almost certain that
After a rough round-trip that had left the "Benzinga 420 Marijuana Index" down about 16% (to 133) in 2014, 2015 began with a bang as traders positioned in front of the debut of CNBC special "Marijuana Country: The Cannabis Boom" and also looked to take advantage of tax-loss selling that continued into the very last moments of 2014. As the month progressed, one-year legalization anniversary retrospectives seemed to lift investor spirits. One of the most surprising developments of the month was with CEN Biotech (CENB), which announced after the close on the 23rd that Creative Edge Nutrition (FITX) would spin out the unit with a NASDAQ listing. While the bashers and shorts scoffed at the announcement, CEO Chaaban agreed to sit down with Matt Finston and Chris Parry (along with Dr. Sam Alawieh) for a fireside chat moderated by Mainstreet reporter Juliette Fairley and webcast live. The CEN Bio team was unable to get Parry on board, but Finston admitted after the meeting that he was impressed with the company's success in its appeal against Lakeshore to the Ontario Municipal Board, which had forced the town to issue final zoning permits to CEN Bio, which Health Canada had then added to its list of approved producers in mid-January. FITX ended up rallying to $0.20 by month-end. No one was ...